Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Other Operating Expenses (2018 - 2022)

Dexcom has reported Other Operating Expenses over the past 6 years, most recently at -$5.7 million for Q4 2022.

  • Quarterly Other Operating Expenses fell 106.72% to -$5.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$5.7 million through Sep 2023, down 106.3% year-over-year, with the annual reading at $87.1 million for FY2021, 3384.0% up from the prior year.
  • Other Operating Expenses was -$5.7 million for Q4 2022 at Dexcom, down from $1.8 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $217.7 million in Q4 2018 and troughed at -$5.7 million in Q4 2022.
  • The 4-year median for Other Operating Expenses is $1.9 million (2022), against an average of $34.1 million.
  • Year-over-year, Other Operating Expenses surged 3292.0% in 2021 and then crashed 106.72% in 2022.
  • A 4-year view of Other Operating Expenses shows it stood at $217.7 million in 2018, then tumbled by 98.85% to $2.5 million in 2020, then surged by 3292.0% to $84.8 million in 2021, then plummeted by 106.72% to -$5.7 million in 2022.
  • Per Business Quant, the three most recent readings for DXCM's Other Operating Expenses are -$5.7 million (Q4 2022), $1.8 million (Q3 2022), and $1.9 million (Q2 2022).